Takahiro Ozawa
Meguro, 1538505, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Observation of proton tunneling correlated with phonons and electrons in Pd.
Journal: Science advances
Published: November 21, 2025
Severe Iron Deficiency Anaemia Caused by bed bug Parasitisation without a Rash.
Journal: European journal of case reports in internal medicine
Published: October 02, 2025
Controlling surface reactions of hydrogen atoms by the electron spin.
Journal: Nature communications
Published: July 24, 2025
Evaluation of a Shortened Quarantine Policy among Healthcare Personnel in a Cancer Center Setting during the Omicron Epidemic in Japan: a Descriptive Epidemiological Study.
Journal: Japanese journal of infectious diseases
Published: March 02, 2025
Germanene Reformation from Oxidized Germanene on Ag(111)/Ge(111) by Vacuum Annealing.
Journal: Small methods
Published: June 10, 2024
First-line osimertinib for poor performance status patients with EGFR mutation-positive non-small cell lung cancer: A prospective observational study.
Journal: Investigational new drugs
Published: October 12, 2021
A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Journal: Cancer management and research
Published: September 22, 2021
Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors.
Journal: Investigational new drugs
Published: February 17, 2020
Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer prior to the approval of durvalumab.
Journal: Thoracic cancer
Published: November 12, 2019
Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non-small cell lung cancer harboring an EGFR mutation: A prospective observational study.
Journal: Thoracic cancer
Published: January 04, 2019
Real-world evaluation of carboplatin plus a weekly dose of nab-paclitaxel for patients with advanced non-small-cell lung cancer with interstitial lung disease.
Journal: Cancer management and research
Published: December 28, 2018
Comparison of carboplatin plus etoposide with amrubicin monotherapy for extensive-disease small cell lung cancer in the elderly and patients with poor performance status.
Journal: Thoracic cancer
Published: April 17, 2018
Last Updated: 09/26/2026